Findings

What do systematic reviews say?

4 questions · 4 findings · 2 reviews · Developmental, Psychosocial and Learning Problems

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 25%GRADE not reported 0 · 0%Very low 3 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Methylphenidate vs placebo or no intervention

Adverse events considered non‐serious (penicillin versus doxycycline) · Children and adolescents with ADHD

It is very uncertain whether methylphenidate changes proportion of participants with one or more adverse events… compared with placebo or no intervention (very low certainty).

1 finding from 1 review

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) 2023 · Cochrane Headline outcomes only
RR 1.23 [1.11, 1.37]
35 studies · 5342 participants
Very low

Antidepressants vs placebo

Non‐serious adverse events Timing of outcome assessment: end of treatment · patients with borderline personality disorder

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mood stabilisers vs placebo

Non‐serious adverse events Timing of outcome assessment: end of treatment · patients with borderline personality disorder

It is very uncertain whether mood stabilisers changes non‐serious adverse events Timing of outcome assessment: end of… compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
RR 0.84
1 study · 276 participants
Very low

Antipsychotics vs placebo

Non‐serious adverse events Timing of outcome assessment: end of treatment · patients with borderline personality disorder

It is very uncertain whether antipsychotics changes non‐serious adverse events Timing of outcome assessment: end of… compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for people with borderline personality disorder 2022 · Cochrane Headline outcomes only
RR 1.07
5 studies · 814 participants
Very low